Goodman Financial Corp Has $17.46 Million Position in Patterson Companies, Inc. (NASDAQ:PDCO)

Goodman Financial Corp raised its holdings in Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 4.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 565,881 shares of the company's stock after acquiring an additional 22,599 shares during the quarter. Patterson Companies comprises 3.7% of Goodman Financial Corp's portfolio, making the stock its 5th largest position. Goodman Financial Corp owned approximately 0.64% of Patterson Companies worth $17,463,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. BNP Paribas Financial Markets increased its stake in shares of Patterson Companies by 31.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 33,257 shares of the company's stock valued at $726,000 after acquiring an additional 7,969 shares during the last quarter. Mork Capital Management LLC grew its holdings in Patterson Companies by 142.9% during the third quarter. Mork Capital Management LLC now owns 84,980 shares of the company's stock valued at $1,856,000 after purchasing an additional 50,000 shares during the period. Barclays PLC increased its stake in Patterson Companies by 37.2% in the third quarter. Barclays PLC now owns 165,715 shares of the company's stock valued at $3,619,000 after purchasing an additional 44,906 shares in the last quarter. EMC Capital Management raised its holdings in Patterson Companies by 600.7% in the fourth quarter. EMC Capital Management now owns 16,053 shares of the company's stock worth $495,000 after purchasing an additional 13,762 shares during the period. Finally, Tritonpoint Wealth LLC bought a new position in shares of Patterson Companies during the fourth quarter worth $264,000. Institutional investors and hedge funds own 85.43% of the company's stock.

Remove Ads

Patterson Companies Stock Up 0.1 %

Shares of NASDAQ PDCO traded up $0.04 during midday trading on Tuesday, reaching $31.24. The company's stock had a trading volume of 662,540 shares, compared to its average volume of 1,017,934. Patterson Companies, Inc. has a fifty-two week low of $19.45 and a fifty-two week high of $31.79. The stock has a 50 day simple moving average of $31.05 and a 200-day simple moving average of $26.30. The stock has a market capitalization of $2.76 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 2.71 and a beta of 0.99. The company has a current ratio of 1.37, a quick ratio of 0.76 and a debt-to-equity ratio of 0.34.

Analyst Ratings Changes

A number of research firms recently commented on PDCO. Piper Sandler lowered their price objective on shares of Patterson Companies from $26.00 to $24.00 and set a "neutral" rating for the company in a research report on Friday, December 6th. Leerink Partnrs downgraded Patterson Companies from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 11th. Morgan Stanley lifted their price objective on Patterson Companies from $27.00 to $31.35 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Robert W. Baird increased their target price on Patterson Companies from $25.00 to $31.00 and gave the stock a "neutral" rating in a research note on Thursday, December 12th. Finally, Leerink Partners reaffirmed a "market perform" rating and issued a $31.35 price target (up previously from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. Eleven research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Patterson Companies presently has a consensus rating of "Hold" and an average target price of $26.57.

About Patterson Companies

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.